zamtocabtagene autoleucel (MB-CART2019.1) clinical trials

DALY II USA/ MB-CART2019.1 for DLBCL

This study is testing a new cell therapy called zamtocabtagene autoleucel for different types of lymphoma, including Diffuse Large B-cell Lymphoma (DLBCL), when other treatments haven't worked. It looks at how well it works and if it's safe.